William Blair Expands Tech-Enabled Services Coverage With Three Senior Investment Banking Hires
CHICAGO & ATLANTA–(BUSINESS WIRE)–William Blair, the premier global boutique with expertise in investment banking, investment…
Month: July 2022
U.S. Enterprises Committing to IoT With Long-Term Plans
Companies want both a future vision and short-term results, with goals for visibility, data analytics…
Keysight Enables MICAS to Obtain One of the First O-RAN Certifications for Open RAN Radio Unit
Comprehensive Keysight portfolio used for O-RAN conformance and certification testing SANTA ROSA, Calif.–(BUSINESS WIRE)–$KEYS #5G—Keysight…
IP Infusion Successfully Validates its Disaggregated Cell Site Gateway for Open Fronthaul Use Cases at O-RAN Global PlugFest Spring 2022
SANTA CLARA, Calif.–(BUSINESS WIRE)–#autonomousnetworks—IP Infusion, a leading provider of open network software and solutions for…
Array Names Alem Sendaba to COO to Further Drive Company Growth
NEW YORK–(BUSINESS WIRE)–Array, a leading financial innovation platform, announced the promotion of Alem Sendaba to…
KBRA Commentary on Primary Tenant in Taurus 2019-1 FR DAC
LONDON–(BUSINESS WIRE)–#KBRA–According to news sources, the Republic of France has announced the nationalisation of energy…
GE Healthcare Unveils Latest Ultra-Premium Ultrasound in Women’s Health Portfolio
Voluson Expert 22 represents a major step forward in ultrasound innovation from a market leader…
Tangoe Launches 1H2022 Market Report
Insight and trends across telecom, mobile and cloud INDIANAPOLIS–(BUSINESS WIRE)–Today, Tangoe, the leading technology expense…
AXIM Biotechnologies Celebrates Feature on the Vision is More Than 20/20™ Podcast
SAN DIEGO, July 21, 2022 (GLOBE NEWSWIRE) — AXIM Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM Biotech,”…
22nd Century Announces $35 Million Registered Direct Offering Priced Above Market under Nasdaq Rules
BUFFALO, N.Y., July 21, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), leading agricultural…
Better Choice Company to Host Second Quarter 2022 Earnings Call on August 11th at 8:30 a.m. ET
NEW YORK, July 21, 2022 (GLOBE NEWSWIRE) — Better Choice Company (NYSE: BTTR) (“Better Choice”…
Achilles Therapeutics to lead Horizon Europe-Funded Consortium to Advance Personalized Cell Therapy Manufacturing
€4 million ($4.2 million) research and innovation award for consortium to develop first-in-class smart bioprocessing…
Collegium to Report Second Quarter 2022 Financial Results on August 4, 2022
STOUGHTON, Mass., July 21, 2022 (GLOBE NEWSWIRE) — Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,…
Pliant Therapeutics Receives FDA Fast Track Designation for PLN-74809 for the Treatment of Primary Sclerosing Cholangitis
SOUTH SAN FRANCISCO, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Pliant Therapeutics (NASDAQ: PLRX) announced…
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth Conference
FREMONT, Calif., July 21, 2022 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”)…
Celldex Announces First Patient Dosed in Phase 2 Study of Barzolvolimab in Patients with Chronic Inducible Urticaria
HAMPTON, N.J., July 21, 2022 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that…
Opus Genetics Expands its Leadership Team
Vikram Arora, Ph.D., DABT, appointed Vice President of Non-Clinical Development Erin O’Neil, M.D., appointed Vice…
Arbutus to Report Second Quarter 2022 Financial Results and Provide Corporate Update
WARMINSTER, Pa., July 21, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
Artizan Biosciences Announces Multi-Year Research Collaboration with the University Medical Center Utrecht and Microviable Therapeutics SL
Research will leverage Artizan’s proprietary IgA-SEQ™ discovery platform to identify gut microbiota that may affect…
BridgeBio Pharma Announces Academic Collaboration with Baylor College of Medicine to Advance Potential Therapies to Treat Genetic Diseases
PALO ALTO, Calif., July 21, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO), a commercial-stage…